Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
EXG102-031 for Wet Age-Related Macular Degeneration
Recruiting1 awardPhase 1
Reno, Nevada
This trial will test if a new drug is safe for people with wet AMD, to stop the abnormal blood vessel growth and leakage that can lead to severe vision loss.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service